| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d07a4ddba85ae3e35ca0a6f85dad9f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90878e49409a29ddc22d50babc6e705a |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate |
2007-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0efddf7a84cfaa4fd42fbedaa678c3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c929f7df4e3116a89031632a884aa300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e03654d5820c28858a1a699bf513a31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b24fae36ccd57049449281786b0296b1 |
| publicationDate |
2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2608002-T3 |
| titleOfInvention |
Methods and compositions for treating and detecting SOD1 mediated diseases misfolded |
| abstract |
A composition suitable for treating amyotrophic lateral sclerosis (ALS), said composition comprising a pharmaceutically acceptable carrier and an agent selected from: (1) an exogenous antibody or a fragment thereof that selectively binds to an epitope consisting of: (a ) IKGLTEGLHGF [DSE5]; (b) GLHGFHVH [DSE7]; or (c) an analog consisting of IKGLTEGLHGF [DSE5] or GLHGFHVH [DSE7], the analog comprising a modification of an amino acid by oxidation or nitration; and (2) an immunogen comprising a peptide of less than 20 residues of SOD1 comprising: a) IKGLTEGLHGF [DSE5]; or b) GLHGFHVH [DSE7]; or c) an analog of a) or b), the analog comprising a modification of an amino acid by oxidation or nitration. |
| priorityDate |
2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |